Covid-19 as a Catalyst for a New Era in Diagnostic Testing

JUN

04

Diagnostics, especially point-of-care testing, are now at the front and center in the fight to control COVID-19. Until this pandemic however, this healthcare sub-sector was generally overlooked and undervalued. Join our MedTech experts, Gerald Schnell and Michael Keller, as they discuss the rise of diagnostics, defining the value of testing and diagnostics’ future potential in our fourth webinar in the LifeSciences on-demand series.

Additionally, you can learn more by reading their article.